
Neurologist

No OPD information available
Stroke
Thrombectomy
Absence Seizure
Carotid Artery Disease
Generalized Tonic-Clonic Seizure
Seizures
Transient Ischemic Attack (TIA)
Angioplasty
Arteriovenous Malformation
Atherosclerosis
Atrial Fibrillation
Brain Aneurysm
CACH Syndrome
Cerebral Cavernous Malformation
Drug Induced Dyskinesia
Embolectomy
Epilepsy
Hypertension
Palatal Myoclonus
Stent Placement
Subarachnoid Hemorrhage
Bernard L. Yan is a male doctor who helps people with different brain and heart problems like stroke, seizures, and artery diseases. He uses special treatments like surgery and stents to help his patients get better. 
Dr. Yan talks to his patients in a kind and clear way, making sure they understand what's happening with their health. Patients trust him because he listens to their concerns and explains things well.
To stay updated with new medical information, Dr. Yan reads research papers and attends conferences. This helps him learn about the latest treatments and techniques to help his patients better.
Dr. Yan works well with other doctors and nurses, sharing his knowledge and skills to provide the best care for patients. He values teamwork and collaboration to make sure everyone is working together for the patients' benefit.
Dr. Yan's work has helped many people improve their health and live better lives. His research on stroke treatments has been published in a medical journal, showing his dedication to finding better ways to help patients recover.
One of his clinical trials, called SELECT2, aimed to find the best treatment for stroke patients. This trial has been completed, and the results will help doctors like Dr. Yan provide even better care for their patients in the future. 
In summary, Bernard L. Yan is a caring and skilled doctor who uses the latest medical knowledge to help his patients with brain and heart problems. His dedication to research and collaboration with other medical professionals shows his commitment to providing the best care possible.
Enrollment Status: Completed
Published: November 21, 2024
Intervention Type: Other, Device
Study Drug:
Study Phase: Not Applicable
